Sirolimus demonstrates activity in the primary therapy of acute graft-versus-host disease without systemic glucocorticoids.
about
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: VI. The 2014 Clinical Trial Design Working Group ReportTransplantation-Associated Thrombotic Microangiopathy in Patients Treated With Sirolimus and Cyclosporine as Salvage Therapy for Graft-Versus-Host Disease.Blood and marrow transplant clinical trials network state of the Science Symposium 2014Have we improved in preventing and treating acute graft-versus-host disease?Thinking out of the box--new approaches to controlling GVHD.The efficacy and safety of sirolimus-based graft-versus-host disease prophylaxis in patients undergoing allogeneic hematopoietic stem cell transplantation: a meta-analysis of randomized controlled trials.Outcomes of high-grade gastrointestinal graft-versus-host disease posthematopoietic stem cell transplantation in childrenNew perspectives on the use of mTOR inhibitors in allogeneic haematopoietic stem cell transplantation and graft-versus-host disease.Graft-versus-host disease therapy: something else beyond glucocorticoids?Everolimus for pediatric patients with acute graft-versus-host disease after hematopoietic stem cell transplantation: A pilot study.New and emerging therapies for acute and chronic graft versus host disease.
P2860
Q26827651-187C4963-1662-4A26-A8FC-F7BB94D51264Q33424311-7920E8C1-620A-45D3-B40D-57476F599A80Q35591760-F2A22C03-7E17-4738-A2AE-5D1619A7ED3BQ36203692-306D1466-EADA-4574-AEE6-EDC88AC0000FQ38175862-622367AA-51E1-4A71-A453-B8EDC213CCEDQ38413246-0E484003-348C-4641-ADCF-EA4929C96A86Q38794077-B8DEB04D-9A71-4DB1-BF62-57DB4FB0405BQ38849186-B9F7BB52-135E-45B5-ABDB-D5D5BB98927FQ43448313-39F95E1A-E5F9-45C1-892A-D2537002DCC0Q47163363-4DE029FD-BA0F-4900-BA86-065CC7DFF24AQ49238507-9290C193-F94A-49FE-A4E8-3912A6201710
P2860
Sirolimus demonstrates activity in the primary therapy of acute graft-versus-host disease without systemic glucocorticoids.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Sirolimus demonstrates activit ...... hout systemic glucocorticoids.
@ast
Sirolimus demonstrates activit ...... hout systemic glucocorticoids.
@en
type
label
Sirolimus demonstrates activit ...... hout systemic glucocorticoids.
@ast
Sirolimus demonstrates activit ...... hout systemic glucocorticoids.
@en
prefLabel
Sirolimus demonstrates activit ...... hout systemic glucocorticoids.
@ast
Sirolimus demonstrates activit ...... hout systemic glucocorticoids.
@en
P2093
P2860
P1433
P1476
Sirolimus demonstrates activit ...... hout systemic glucocorticoids.
@en
P2093
Claudio Anasetti
Ernesto Ayala
Fred Locke
Hugo Fernandez
Janelle Perkins
Jose Leonel Ochoa
Joseph Pidala
Marcie Tomblyn
Melissa Alsina
P2860
P304
P356
10.3324/HAEMATOL.2011.041236
P577
2011-05-12T00:00:00Z